pneumococc
surfac
protein
pspa
play
key
role
pathogenesi
invas
pneumococc
infect
pspa
might
modul
specif
immun
respons
human
popul
circul
monocyt
essenti
innat
respons
subsequ
acquir
immun
respons
streptococcu
pneumonia
studi
investig
effect
pspa
cytokin
chemokin
secret
human
peripher
blood
monocyt
underli
intracellular
signal
mechan
stimul
monocyt
purifi
pspa
protein
induc
signific
releas
inflammatori
cytokin
chemokin
includ
product
pspadefici
mutant
pneumococcu
express
pspa
induc
significantli
less
secret
mediat
wild
type
pneumococcu
investig
show
pspa
activ
extracellular
signalregul
kinas
erk
cjun
ntermin
kinas
jnk
mitogen
activ
protein
kinas
mapk
nuclear
factor
nf
kb
signal
pathway
human
monocyt
moreov
inhibit
pathway
use
select
inhibitor
could
significantli
reduc
cytokin
chemokin
secret
induc
pspa
taken
togeth
find
provid
insight
pspamedi
activ
human
monocyt
via
nfkb
mapk
signal
cascad
pathogenesi
invas
pneumococc
infect
streptococcu
pneumonia
major
caus
seriou
invas
infecti
diseas
pneumonia
bacteremia
mening
estim
invas
pneumococc
infect
result
estim
million
death
everi
year
thu
pneumococc
diseas
remain
major
globalhealth
issu
mani
year
well
known
antiphagocyt
polysaccharid
capsul
import
virul
factor
pneumonia
past
year
import
pneumococc
protein
virul
pneumonia
clarifi
either
mediat
inflamm
directli
attack
host
tissu
pneumococcu
signific
attenu
virul
mutat
gene
encod
pneumococc
virul
protein
therefor
pneumococc
virul
protein
play
crucial
role
pathogenesi
pneumococc
infect
comprehens
understand
interact
pneumococc
virul
protein
host
cell
may
help
develop
novel
therapeut
agent
pneumococc
infect
pneumococc
surfac
protein
pspa
first
identifi
use
monoclon
antibodi
rais
surfac
determin
pneumonia
pspa
cholinebind
surfac
protein
compos
five
domain
signal
peptid
ahel
domain
prolinerich
region
cholinebind
domain
ctermin
tail
pspa
present
surfac
pneumococcu
highli
variabl
base
sequenc
ntermin
pspa
group
three
famili
subdivid
six
differ
clade
pspa
lactoferrinbind
protein
pneumonia
may
overcom
iron
limit
lactoferrinpspa
interact
also
reduc
amount
deposit
onto
pneumococcu
antibodi
pspa
could
increas
complement
activ
deposit
shaper
et
al
demonstr
pspa
could
protect
pneumonia
kill
apolactoferrin
antipspa
antibodi
could
enhanc
kill
pneumococcu
apolactoferrin
recent
studi
indic
pspa
contribut
secondari
pneumonia
infect
influenza
viru
infect
pspa
great
potenti
effect
vaccin
candid
system
mucos
immun
pspa
could
elicit
effect
protect
pneumococcc
infect
capac
pspa
protect
pneumococc
diseas
remain
determin
import
implic
pneumococc
vaccin
develop
monocyt
circul
blood
leukocyt
involv
pathogenesi
inflammatori
diseas
essenti
innat
respons
subsequ
acquir
immun
respons
pathogen
activ
monocyt
transduc
proinflammatori
signal
gener
larg
amount
reactiv
oxygen
speci
ro
complement
factor
prostaglandin
nitric
oxid
cytokin
chemokin
proteolyt
enzym
mediat
play
import
role
defens
invad
pathogen
upon
pneumococcu
entri
bloodstream
invas
pneumococc
infect
like
regul
contact
naiv
monocyt
result
activ
monocyt
inflammatori
respons
final
opsonindepend
phagocytosi
howev
studi
investig
inflammatori
effect
interact
pneumonia
monocyt
owe
key
role
monocyt
innat
adapt
immun
import
pspa
virul
pneumonia
investig
effect
pspa
proinflammatori
paramet
human
monocyt
e
name
secret
cytokin
chemokin
studi
demonstr
pspa
could
modul
function
human
monocyt
e
least
part
e
activ
intracellular
nuclear
factor
nf
kb
mitogen
activ
protein
kinas
mapk
pathway
actinomycin
cycloheximid
purchas
sigmaaldrich
ikba
phosphoryl
inhibitor
extracellular
signalregul
kinas
erk
inhibitor
cjun
ntermin
kinas
jnk
inhibitor
mapk
inhibitor
phosphatidylinositol
kinas
inhibitor
janu
kinas
jak
inhibitor
purchas
calbiochem
corp
ca
usa
dissolv
water
dissolv
dimethyl
sulfoxid
dmso
studi
concentr
dmso
volvol
cell
cultur
medium
purchas
gibco
invitrogen
corp
ca
usa
free
detect
lp
euml
solut
prepar
use
pyrogenfre
water
steril
polypropylen
plasticwar
solut
contain
detect
lp
determin
limulu
amoebocyt
lyas
assay
sensit
limit
pgml
biowhittak
inc
md
usa
pspadefici
pspa
mutant
pneumococcu
establish
describ
previous
pspa
delet
mutant
construct
pcrsynthesi
method
use
marker
cassett
long
flank
homolog
region
contain
erythromycin
cassett
northern
blot
analysi
pspa
transcript
gene
upstream
downstream
pspa
suggest
pspa
promot
mutat
polar
effect
mutant
pneumococcu
cultur
c
medium
c
exponenti
phase
centrifug
g
min
cultur
supernat
collect
filter
mm
pore
concentr
vivaspin
western
blot
confirm
presenc
pspa
cc
expect
absenc
cc
deriv
mutant
strain
data
shown
recombin
pspa
aa
molecular
weight
approxim
kda
clone
escherichia
coli
polymeras
chain
reaction
pcr
amplif
dna
strain
code
sequenc
pspa
correspond
matur
ntermin
region
pspa
includ
ahel
domain
prolinerich
region
purifi
pspa
contain
plasmidencod
thioredoxin
trx
polyhistidin
tag
futur
protein
function
studi
necessari
remov
tag
trx
fusion
protein
trxhispspa
protein
extra
amino
acid
may
elicit
unwant
immun
respons
dialysi
pb
concentr
identifi
trxhispspa
determin
protein
assay
reagent
pierc
inc
rockford
usa
recombin
enterokinas
ad
unitweight
ratio
proteas
fusion
protein
reaction
incub
variou
time
durat
rang
h
room
temperatur
confirm
success
complet
protein
cleavag
sdsepag
analysi
ekaptur
agaros
ad
remov
residu
recombin
enterokinas
column
ni
enta
agaros
resin
employ
isol
remov
ntermin
fusion
protein
trxhi
target
pspa
recombin
protein
confirm
two
fragment
trxhi
pspa
readili
separ
sdsepag
analysi
target
pspa
protein
lyophil
store
c
use
primari
blood
monocyt
surfac
marker
express
isol
buffi
coat
heparin
blood
sampl
donat
healthi
volunt
use
ficollpaqu
pharmacia
biotech
uppsala
sweden
densiti
gradient
centrifug
monocyt
purifi
cell
magneticactiv
cell
sort
mac
system
use
magnet
bead
miltenyi
biotec
auburn
ca
cell
viabil
measur
trypan
blue
exclus
assay
puriti
monocyt
verifi
fluorescenceactiv
cell
sort
fac
use
peconjug
antibodi
beckman
coulter
miami
fl
purifi
monocyt
cultur
rpmi
medium
gibco
usa
supplement
fb
mm
hepe
gibco
usa
inhibit
experi
human
monocyt
pretreat
signal
molecul
inhibitor
hour
quantit
analysi
tumor
necrosi
factor
tnf
concentr
inflammatori
cytokin
tnfa
chemokin
cultur
supernat
human
monocyt
cell
treatment
h
h
determin
elisa
kit
bd
pharmingen
ca
usa
rest
pspastimul
ngml
human
monocyt
cell
fix
equal
volum
prewarm
bd
cytofix
buffer
immedi
min
stimul
collect
centrifug
g
min
bd
phosflow
perm
buffer
iii
ml
ad
permeabil
cell
min
ice
cell
wash
twice
resuspend
bd
pharmingen
stain
buffer
incub
mous
antihuman
phosphoerk
phosphojnk
phosphoryl
ikba
monoclon
antibodi
mous
isotyp
c
h
follow
incub
fitc
conjug
goat
antimous
secondari
antibodi
c
min
dark
final
wash
cell
resuspend
paraformaldehyd
pb
quantit
analysi
express
intracellular
phosphoryl
signal
molecul
viabl
cell
term
mean
fluoresc
intens
mfi
perform
flow
cytometri
bd
facscalibur
flow
cytomet
human
monocyt
cell
wash
icecold
pb
lyse
ml
lysi
buffer
mm
trisehcl
mm
nacl
triton
mm
ethylenediaminetetraacet
acid
mm
ethyleneglycoltetraacet
acid
proteas
inhibitor
cell
debri
remov
centrifug
g
min
supernat
quantifi
coomassietm
protein
assay
reagent
boil
laemmli
sampl
buffer
biorad
laboratori
hercul
ca
min
equal
amount
protein
subject
sdpage
blot
onto
polyvinyliden
difluorid
membran
amersham
pharmacia
biotech
membran
block
skim
milk
trisbuff
salin
ph
h
room
temperatur
probe
antihuman
total
phosphorylatederk
antihuman
total
phosphorylatedjnk
antihuman
total
mapk
antihuman
total
phosphorylatedikba
monoclon
antibodi
cell
signal
technolog
inc
beverli
c
overnight
wash
membran
incub
secondari
donkey
antirabbit
antibodi
coupl
horseradish
peroxidas
amersham
pharmacia
biotech
h
room
temperatur
antibodyeantigen
complex
detect
use
enhanc
chemiluminesc
ecl
detect
system
accord
manufactur
instruct
amersham
pharmacia
biotech
western
blot
phosphoryl
protein
analysi
reprob
antibodi
total
erk
jnk
ikba
demonstr
equal
protein
load
data
express
mean
ae
sd
differ
group
assess
one
way
anova
analysi
bonferroni
post
hoc
test
student
ttest
probabl
p
consid
significantli
differ
analys
perform
use
statist
packag
social
scienc
spss
statist
softwar
window
version
spss
inc
il
usa
effect
pspa
secret
human
monocyt
use
limulu
amoebocyt
lyas
assay
firstli
confirm
recombin
pspa
solut
free
detect
lp
euml
gener
profil
cytokin
chemokin
may
regul
pspa
effect
pspa
inflammatori
cytokin
chemokin
includ
examin
human
monocyt
cell
stimul
indic
concentr
pspa
indic
time
fig
experiment
condit
use
experi
cell
viabil
consist
indic
recombin
pspa
prepar
use
induc
signific
death
monocyt
found
pspa
significantli
induc
b
c
e
secret
comparison
control
time
point
secret
mediat
induc
pspa
could
enhanc
dosedepend
ngml
h
addit
maxim
respons
occur
h
pspa
stimul
mediat
howev
secret
inflammatori
cytokin
tnfa
chemokin
could
induc
pspa
human
monocyt
fig
besid
found
pspa
activ
could
enhanc
capac
human
monocyt
intern
clear
pneumococcu
direct
function
test
vitro
data
shown
verifi
cytokin
chemokin
secret
monocyt
newli
synthes
upon
stimul
pspa
transcript
inhibitor
actinomycin
protein
synthesi
inhibitor
cycloheximid
use
shown
fig
aee
actinomycin
mm
cycloheximid
mm
alon
could
significantli
suppress
secret
cytokin
chemokin
induc
pspa
signific
cell
toxic
dose
use
result
therefor
indic
pspa
actual
induc
secret
newli
synthes
rather
preform
one
monocyt
modul
secret
pneumococc
cultur
supernat
human
monocyt
stimul
cc
deriv
strain
medium
alon
secret
cytokin
chemokin
analyz
elisa
shown
fig
aee
cc
wild
type
treatment
associ
signific
increas
secret
howev
cc
pspadefici
mutant
pneumococcu
induc
significantli
less
secret
cytokin
chemokin
cytotox
differ
signal
molecul
inhibitor
human
monocyt
firstli
determin
bromid
mtt
assay
use
optim
concentr
mm
mm
mm
mm
mm
mm
signific
inhibitori
effect
without
cell
toxic
shown
fig
aee
could
partial
significantli
suppress
secret
howev
exert
signific
effect
cytokin
chemokin
secret
induc
pspa
regard
signal
transduct
mechan
took
advantag
rapid
quantit
method
use
intracellular
fluoresc
stain
flow
cytometri
measur
content
phosphoryl
erk
jnk
ikba
permeabil
monocyt
repres
flow
cytometri
histogram
fig
illustr
untreat
human
monocyt
basal
activ
erk
jnk
mapk
ikba
howev
human
monocyt
treat
pspa
min
shown
significantli
upregul
express
phosphoryl
erk
jnk
mapk
ikba
phosphoryl
erk
jnk
mapk
ikba
highli
reproduc
detect
human
monocyt
min
stimul
pspa
mean
western
blot
fig
data
confirm
result
inhibitor
assay
describ
human
monocyt
play
import
role
pathogenesi
bacteri
infecti
diseas
demonstr
monocyt
key
effector
clear
primari
pneumococc
colon
sinc
invas
pneumococc
infect
like
regul
contact
naiv
monocyt
pneumococcu
enter
bloodstream
cell
good
target
host
againstpneumococcu
action
product
cytokin
chemokin
regul
immun
respons
among
virul
protein
pneumonia
known
pspa
surfaceexpos
protein
may
secret
vivo
pspa
known
import
factor
pathogenesi
invas
pneumococc
infect
previou
studi
demonstr
opaqu
strain
show
improv
surviv
bloodstream
bear
protect
antigen
pspa
furthermor
ogunniyi
ad
et
al
found
express
pspa
upregul
threefold
h
postinfect
higher
h
postinfect
studi
stimul
human
peripher
blood
monocyt
recombin
pspa
shown
first
time
pspa
could
induc
secret
inflammatori
cytokin
chemokin
includ
howev
pspa
could
activ
human
monocyt
secret
tnfa
explan
may
pspa
activ
gene
transcript
select
regul
induct
differ
cytokin
chemokin
activ
differ
transcript
factor
although
cc
contain
varieti
nativ
compon
releas
pspadefici
mutant
pneumococcu
express
pspa
could
induc
significantli
secret
mediat
control
medium
secret
mediat
significantli
less
cc
wild
type
pneumococcu
sinc
cc
pspadefici
mutant
pneumococcu
absent
full
truncat
pspa
confirm
western
blot
conclud
nativ
pspa
pneumococcu
induc
addit
given
known
polymorph
variat
pspa
differ
pneumococc
strain
studi
requir
explor
impact
differ
secret
newli
synthes
mediat
respons
pspa
inflammatori
cytokin
secret
varieti
cell
type
includ
monocyt
induc
synthesi
acutephas
protein
regul
variou
immun
inflammatori
respons
previou
studi
demonstr
one
essenti
cytokin
induc
differenti
human
th
cell
sinc
shown
increas
pneumococc
kill
human
neutrophil
may
therefor
play
import
role
mediat
pneumococc
immun
human
among
chemokin
induc
pspa
chemoattract
monocyt
besid
also
induc
releas
lysosom
enzym
product
superoxid
anion
express
cytokin
chemokin
macrophag
overexpress
mice
show
improv
pneumococc
clearanc
surviv
associ
substanti
increas
lung
mononuclear
phagocyt
subset
accumul
regul
variou
biolog
function
neutrophil
includ
chemotaxi
degranul
superoxid
product
express
adhes
molecul
preferenti
attract
cell
also
involv
activ
human
granulocyt
seem
involv
acut
neutrophil
inflamm
chemotact
tcell
monocyt
eosinophil
basophil
play
activ
role
recruit
leukocyt
inflammatori
site
taken
togeth
inflammatori
factor
induc
pspa
may
regul
initi
mainten
termin
inflammatori
reaction
invas
pneumococc
infect
intracellular
signal
mechan
regul
pspainduc
inflammatori
cytokin
chemokin
secret
human
monocyt
complet
understood
signal
transduct
cascad
fine
tune
control
gene
express
via
phosphoryl
variou
protein
kinas
target
protein
upon
variou
extracellular
stimul
investig
underli
molecular
mechan
examin
role
nfkb
mapk
pathway
use
pharmacolog
approach
pspainduc
secret
significantli
decreas
ikba
map
kinas
inhibitor
suggest
involv
pathway
pneumococc
inflammatori
diseas
howev
either
inhibit
erk
jnk
mapk
nfkb
pathway
could
partial
diminish
induc
secret
mediat
pspa
result
indic
three
mapk
pathway
nfkb
pathway
partli
predominantli
involv
induct
furthermor
differenti
activ
differ
intracellular
signal
mechan
andor
differenti
regul
variou
transcript
factor
secret
cytokin
chemokin
human
monocyt
exclud
requir
investig
elev
express
intracellular
phosphoryl
mapk
protein
hallmark
activ
mapk
signal
pathway
nfkb
signal
pathway
phosphoryl
subsequ
degrad
nfkb
inhibitor
ikba
requir
allow
nfkb
nuclear
transloc
nfkb
sequest
cytoplasm
associ
inhibitor
protein
ikba
ikba
phosphoryl
degrad
proteasom
free
nfkb
transloc
nucleu
regul
gene
express
use
intracellular
stain
flow
cytometri
western
blot
investig
phosphoryl
level
signal
molecul
monocyt
confirm
pspa
could
induc
phosphoryl
erk
jnk
mapk
ikba
human
monocyt
suggest
pneumococc
pspa
could
activ
erk
jnk
mapk
nfkb
signal
pathway
nfkband
mapksdepend
chemokin
synthesi
human
antigenpres
dendrit
cell
respons
pneumococc
protein
pneumolysin
cholin
bind
protein
cbpa
also
report
therefor
activ
nfkb
mapk
signal
pathway
involv
pneumococc
infect
fact
enhanc
mapk
express
mononuclear
cell
investig
sever
acut
respiratori
syndrom
therefor
better
understand
signal
pathway
involv
invas
pneumococc
infect
may
import
develop
strategi
reduc
septic
inflamm
associ
invas
pneumococc
infect
previou
report
demonstr
mani
differ
pneumococc
protein
capabl
induc
releas
proinflammatori
mediat
exampl
recombin
cbpa
could
induc
increas
secret
effect
pspa
phosphoryl
intracellular
erk
jnk
mapk
ikba
signal
molecul
human
monocyt
cell
incub
without
pspa
ngml
min
amount
intracellular
phosphoryl
signal
molecul
permeabil
monocyt
measur
flow
cytometri
histogram
show
overlay
phosphoryl
signal
molecul
medium
control
pspastimul
monocyt
isotyp
control
repres
experi
shown
result
phosphoryl
erk
phosphoryl
jnk
phosphoryl
mapk
phosphoryl
ikba
also
shown
mfi
subtract
correspond
isotyp
control
express
arithmet
mean
plu
sd
independ
experi
perform
cell
isol
differ
donor
p
vs
medium
control
ctl
control
medium
increas
express
intercellular
adhes
molecul
human
alveolar
epitheli
cell
line
cell
pneumolysin
induc
express
tnfa
raw
macrophag
esteras
esta
pneumococcu
induc
tnfa
mrna
raw
macrophag
ferreira
et
al
recent
report
pspa
novel
induc
ifng
two
import
cytokin
involv
protect
effect
pneumococc
infect
howev
first
studi
shown
pspa
could
stimul
releas
human
peripher
blood
monocyt
via
intracellular
nfkb
mapk
signal
pathway
suggest
proand
antiinflammatori
cytokin
differenti
regul
vivo
humor
respons
pneumonia
fact
complex
seri
interact
among
immun
epitheli
vascular
system
cell
well
pneumococc
virul
factor
seem
respons
outcom
invas
pneumococc
infect
one
import
virul
factor
pneumococcu
studi
pspa
provid
new
insight
pspamedi
activ
monocyt
via
differenti
intracellular
signal
cascad
pneumococc
infect
work
identifi
potenti
recognit
receptor
pspa
human
monocyt
ongo
present
find
may
also
import
implic
develop
effect
vaccin
therapeut
agent
pneumococc
infect
